Skip to content
Monday 10 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,892.62
-0.08%
DAX
26,354.43
+0.13%
CAC 40
8,716.83
+0.02%
STOXX 50
6,532.91
+0.14%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

Personnel

  • Everest Appoints Lisa Davis to Lead North America Wholesale & Specialty Business

    May 7, 2026

    Everest Group, Ltd. (“Everest” or “the Company”) (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, today announced the appointment of Lisa Davis as Head of North America, Wholesale & Specialty. Ms. Davis will lead Everest’s North America Wholesale & Specialty business, overseeing underwriting strategy, distribution, and portfolio management across the [...]

  • Options Technology Appoints Larry Leibowitz as Chairman of The Board

    May 6, 2026

    Options Technology, the leading managed IT services and technology solutions provider, today announced Larry Leibowitz to Chairman of its Board. Leibowitz, who joined the Board in June 2023 as an independent director, assumes the Chairmanship as Options continues to accelerate its growth across key financial centres worldwide. This press release features multimedia. View the full [...]

  • Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent

    May 5, 2026

    Highly experienced partners bringing 25+ years of leadership across top-tier life-sciences investment fund, pharma and Biopharma companies, driving accelerated portfolio development With leadership experience at Blackstone Life Sciences (Deputy Chief Operating Officer), Biogen, (NASDAQ: BIIB), and public and private Biopharma companies (including Kymera Therapeutics (NASDAQ: KYMR) and Cygnal Therapeutics), Elaine Caughey will support portfolio companies in strengthening operational execution, defining robust market access pathways, and enhancing their strategic value through business development support, including partnerships and acquisition transactions. She will also draw on her knowledge of the investment ecosystem to strengthen relationships with investors for both Jeito funds and its portfolio companies Sarah brings deep strategic expertise from senior roles at leading Biopharma investment firms - including as Partner, Marketing and Talent at Abingworth and as Chief Talent Officer at Oxford Science Enterprises - and top executive search firms including Coulter Partners and Spencer Stuart. She will focus on building exceptional senior leadership teams and boards across Jeito and its portfolio, attracting the high calibre talent that powers company acceleration and scale

  • euroAtlantic Airways Appoints Pauls Calitis as CEO to Lead Next Phase of Growth

    May 5, 2026

    euroAtlantic Airways (“EAA”), a leading global provider of passenger widebody aircraft wet-leasing and charter services, and Njord Partners portfolio company, is pleased to announce the appointment of Pauls Calitis as Chief Executive Officer, effective 18 May 2026. Pauls will succeed Stewart Higginson, who has served as CEO since early 2024 and who will assume the [...]

  • Kolibri Global Energy Inc. Announces 2026 AGM Results

    May 4, 2026

    Kolibri Global Energy Inc. (the “Company” or “Kolibri“) (TSX: KEI, NASDAQ: KGEI) is pleased to announce the results of the Annual General Meeting of shareholders of the Company held in Marina del Rey, California on May 4, 2026. All of the resolutions put forward at the meeting were approved. The Company’s shareholders voted to fix [...]

  • Grindr Nominates Three New Directors to Its Board of Directors

    April 30, 2026

    Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced the nomination of Rob Solomon, Lisa Gersh, and Fadi Hanna to stand for election to its Board of Directors at the Annual Meeting of Shareholders on June 2, 2026. Rob Solomon is a deeply seasoned technology CEO and operator in consumer internet and [...]

  • Pyxis Group Appoints Kunal Ramtri and Tun Win as Managing Directors to Lead Global Commodities Trading and Risk Practice and Accelerate AI-Driven Growth

    April 30, 2026

    Pyxis Group, a diversified advisory firm serving the global industrial and commodities sectors, today announced the appointments of Kunal Ramtri and Tun Win as Managing Directors and co-heads of the firm’s Global Commodities Trading & Risk practice and Trading AI practice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430123690/en/ Kunal Ramtri brings [...]

  • Driscoll’s Names Wyard Stomp Chief Operating Officer and Expands Shaily Sanghvi’s Role to Lead Global Strategy

    April 29, 2026

    Leadership announcements advance Driscoll's global ambition to scale its proven mission of delighting consumers to every market worldwide

  • Frontier Scientific Solutions Appoints Michelle D’Angelo as Chief Commercial Officer

    April 29, 2026

    Seasoned life sciences commercial leader will focus on driving growth and customer strategy amid global expansion

  • Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights

    April 23, 2026

    Strong FY2025 financial and sustainability results; leadership transition will support continuity and long-term growth Revenue up 8.2% to €3.6bn with double-digit growth in Rare Diseases and U.S. market Air sales at €1.886bn, growing 3.9% vs. 2024 - Care sales at €904m growing 13.3% vs. 2024 - Rare sales at €906m, growing 22.3% vs. 2024 Giuseppe Accogli leaving to pursue another opportunity, Group CFO Jean-Marc Bellemin named Interim CEO while new CEO search is underway Record €885m Research & Development (R&D) investment underscores continued commitment to innovation across respiratory, rare disease and specialty care Sustainability leadership further strengthened through B Corp recertification and progress on Carbon Minimal Inhaler (CMI) innovation

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Page 18
  • Next

Trending Articles

  • Revolut lands fresh banking licence after wrestling with Europe friction

  • Burnham takes on ‘rip-off’ discounts and subscriptions in cost of living push

  • Plus500 splashes cash on investors after US expansion bears fruit

  • FTSE 100 Live: Stocks to drop as US-Iran peace stalls; Oil climbs higher

  • Burnham is wrong. Devolution will only grow Whitehall

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook